Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Maria-Eva Mingot-Castellano

Responsable Banco de Sangre y Tejidos

Hospital Universitario Virgen del Rocío

Spain

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Spain

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (7)

Marienn Réti

Head of the Innovative Cell Therapy Center (formerly: Apheresis and Stem Cell Processing Unit)

HUNGARY

View details

Paul Knoebl

Head

Medical University of Vienna

AUSTRIA

View details

Javier de la Rubia

Head of Department

Hospital Universitari i Politècnic La Fe

SPAIN

View details

Bernhard Lämmle

Senior Professor

Johannes Gutenberg Universität Mainz

GERMANY

View details

Michele P. Lambert

Children's Hospital of Philadelphia

UNITED STATES

View details

José María Bastida

SPAIN

View details

Kazuya Sakai

Senior Lecturer

Nara Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Maria-Eva Mingot-Castellano

Research Interests

Make your next move.

Explore related searches

Articles (20)

A Clinician Perspective for a Personalized Approach to Management of Chronic Immune Thrombocytopenia with Targeted Therapies Alone or in Combination

Navigating the Hemostatic Balance: Anticoagulation and Antiplatelet Therapy in Patients with Thrombocytopenia

Combining an immunomodulatory drug with a TPO‐RA to treat multirefractory ITP patients: The Spanish ITP Group experience

Infectious complications in acquired hemophilia A: insights from the Spanish registry (AHASR)

Irregular antibodies in pregnancy during the universal anti-RHD prophylaxis era: a survey of Spanish Hospitals

Perioperative and periprocedural management of antithrombotic therapy: 2025 consensus document of SEC, SEDAR, SEACV, SECCE, AEC, SECOM CYC, SECPRE, SEPD, SEGG, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEN, S.E.N., SENEC, SEPAR, SEO, SEORL-CCC, SEPA, SERVEI, SECOT, and AEU

Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project).

Thrombotic thrombocytopenic purpura

A multicenter, randomized, open-label study of dexamethasone versus romiplostim plus dexamethasone as first line treatment in patients with newly diagnosed immune thrombocytopenia: Interim results of rodex study

A phase 1/2 safety and efficacy study of TAK-754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials

Caplacizumab Added to Plasma Exchange and Immunosuppression Accelerates Recovery and Improves Survival in Immune-Mediated TTP: an International Real-World Study of the IWG-TTP (The Capla 1000+Project)

Caplacizumab treatment in elderly patients with iTTP: Experience from the Spanish TTP Registry

Clinical characteristics, treatment strategies, and response patterns in evans syndrome: Initial analysis from the spanish resti cohort

Comparative analysis of toxicity and efficacy of melphalan at doses of 140 mg/m2 VS. 200 mg/m2 as a conditioning regimen prior to autologous stem cell transplantation

Implementation of 2020 international guidelines in acquired hemophilia: Insights from a decade of national registry data in Spain

Manejo periquirúrgico de los pacientes con coagulopatías adquiridas inmunitarias

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

Review of the management of patients with immune thrombotic thrombocytopenic purpura with persistently low adamts-13 activity-a challenge beyond rarity

Switching ITP patients to avatrombopag from other TPO-ras: A real-world experience of the spanish ITP group (GEPTI)

Collaborators (7)

Marienn Réti

Paul Knoebl

Javier de la Rubia

Bernhard Lämmle

Michele P. Lambert

José María Bastida

Kazuya Sakai

Make your next move.